Development of an Animal Model of Fibrous Cholangitis in Pigs

REFERENCES

• Botero D. Chemotherapy of human intestinal parasitic diseases. Annu Rev Pharmacol Toxicol. 1978;18:1–15.
   PubMed Web of Science ®Google Scholar
• Ahmed SH, Vaishnava S. Trial of a new anthelmintic (bitoscanate) in ancylostomiasis in children. Prog Drug Res. 1975;19:2–5.
   PubMedGoogle Scholar
• Goldsmid JM, MacCabe RJ. Preliminary studies on the use pf phenylene-diisothiocyanate-(1,4) in the treatment of hookworm and Ternidens deminutus infections in Rhodesia. Cent Afr J Med. 1972;18(11):227–229.
   PubMedGoogle Scholar
• Holz J, Adhman D, Gunardi AT, A single dose of Jonit in the treatment of human ancylostomiasis. Southeast Asian J Trop Med Public Health 1972;3(1):99–102.
   PubMedGoogle Scholar
• O'Holohan DR, Hugoe-Matthews J. Single dose regimens of phenylene di-iso-thiocyanate (1,4) Jonit, in the treatment of hookworm infestation in Malaysia. Southeast Asian J Trop Med Public Health 1972;3(3):403–410.
   PubMedGoogle Scholar
• Botero D, Perez A. Clinical evaluation of a new drug for the treatment of ancylostomiasis. Am J Trop Med Hyg. 1970;19(3):471–475.
   PubMed Web of Science ®Google Scholar
• Hill DA, Jean PA, Roth RA. Bile duct epithelial cells exposed to alpha-naphthylisothiocyanate produce a factor that causes neutrophil-dependent hepatocellular injury in vitro. Toxicol Sci. 1999;47(1):118–125.
   PubMed Web of Science ®Google Scholar
• Svegliati-Baroni G, De Minicis S, Marzioni M. Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. Liver Int. 2008;28(8):1052–1064.
   PubMed Web of Science ®Google Scholar
• Ogawa T, Suruga K, Kojima Y, Experimental study of the pathogenesis of infantile obstructive cholangiopathy and its clinical evaluation. J Pediatr Surg. 1983;18(2):131–135.
   PubMed Web of Science ®Google Scholar
• Heistermann HP, Palmes D, Stratmann U, A new technique for reconstruction of the common bile duct by an autologous vein graft and a biodegradable endoluminal stent. J Invest Surg. 2006;19(1):57–60.
   PubMed Web of Science ®Google Scholar
• Katsimpoulas M, Zacharoulis D, Rountas C, Minimal invasive technique for gene delivery in porcine liver lobe segment. J Invest Surg. 2011;24(1):13–17.
   PubMed Web of Science ®Google Scholar
• Srinivasan A, Trus TL, Conrad AJ, Scarbrough TJ. Common laparoscopic procedures in swine: a review. J Invest Surg. 1999;12(1):5–14.
   PubMed Web of Science ®Google Scholar
• Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington DC: The National Academies Press; 2011.
   Google Scholar
• Priester S, Wise C, Glaser SS. Involvement of cholangiocyte proliferation in biliary fibrosis. World J Gastrointest Pathophysiol. 2010;1(2):30–37.
   PubMedGoogle Scholar
• Barbatis C, Grases P, Shepherd HA, Histological features of sclerosing cholangitis in patients with chronic ulcerative colitis. J Clin Pathol. 1985;38(7):778–783.
   PubMed Web of Science ®Google Scholar
• Nakanuma Y. Tutorial review for understanding of cholangiopathy. Int J Hepatol. 2012;2012:547840.
   PubMedGoogle Scholar
• Sasaki M, Ikeda H, Nakanuma Y. Expression profiles of MUC mucins and trefoil factor family (TFF) peptides in the intrahepatic biliary system: physiological distribution and pathological significance. Prog Histochem Cytochem. 2007;42(2):61–110.
   PubMedGoogle Scholar
• Desmet VJ. Destructive intrahepatic bile duct diseases. Recenti Prog Med. 1990;81(6):392–398.
   PubMedGoogle Scholar
• Sokol RJ, Mack C, Narkewicz MR, Karrer FM. Pathogenesis and outcome of biliary atresia: current concepts. J Pediatr Gastroenterol Nutr. 2003;37(1):4–21.
   PubMed Web of Science ®Google Scholar
• HH AK, El-Ayyouti M, Hawas S, HLA in Egyptian children with biliary atresia. J Pediatr. 2002;141(3):432–433.
   PubMed Web of Science ®Google Scholar
• Chapman RW. Role of immune factors in the pathogenesis of primary sclerosing cholangitis. Semin Liver Dis. 1991;11(1):1–4.
   PubMed Web of Science ®Google Scholar
• Isoyama K, Yamada K, Ishikawa K, Sanada Y. Coincidental cases of primary sclerosing cholangitis and biliary atresia in siblings? Acta Paediatr. 1995;84(12):1444–1446.
   PubMed Web of Science ®Google Scholar
• Sisto A, Feldman P, Garel L, Primary sclerosing cholangitis in children: study of five cases and review of the literature. Pediatrics 1987;80(6):918–923.
   PubMed Web of Science ®Google Scholar
• Roberts EA. Primary sclerosing cholangitis in children. J Gastroenterol Hepatol. 1999;14(6):588–593.
   PubMed Web of Science ®Google Scholar
• Schreiber RA, Kleinman RE. Genetics, immunology, and biliary atresia: an opening or a diversion? J Pediatr Gastroenterol Nutr. 1993;16(2):111–113.
   PubMed Web of Science ®Google Scholar
• Reynoso-Paz S, Coppel RL, Mackay IR, The immunobiology of bile and biliary epithelium. Hepatology 1999;30(2):351–357.
   PubMed Web of Science ®Google Scholar
• Mack CL, Tucker RM, Sokol RJ, Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation. Pediatr Res. 2004;56(1):79–87.
   PubMed Web of Science ®Google Scholar
• Dillon P, Belchis D, Tracy T, Increased expression of intercellular adhesion molecules in biliary atresia. Am J Pathol. 1994;145(2):263–267.
   PubMed Web of Science ®Google Scholar
• Bezerra JA, Tiao G, Ryckman FC, Genetic induction of proinflammatory immunity in children with biliary atresia. Lancet 2002;360(9346):1653–1659.
   PubMed Web of Science ®Google Scholar
• Ramm GA, Nair VG, Bridle KR, Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia. Am J Pathol. 1998;153(2): 527–535.
   PubMed Web of Science ®Google Scholar
• Tan CE, Driver M, Howard ER, Extrahepatic biliary atresia: a first-trimester event? Clues from light microscopy and immunohistochemistry. J Pediatr Surg. 1994;29(6):808–814.
   PubMed Web of Science ®Google Scholar
• Tan CE, Vijayan V. New clues for the developing human biliary system at the porta hepatis. J Hepatobiliary Pancreat Surg. 2001;8(4):295–302.
   PubMedGoogle Scholar
• Tan CE, Moscoso GJ. The developing human biliary system at the porta hepatis level between 11 and 25 weeks of gestation: a way to understanding biliary atresia. Part 2. Pathol Int. 1994;44(8):600–610.
   PubMed Web of Science ®Google Scholar
• Petersen M, Drews U, Schweizer P. Induction of bile ducts in embryonic liver by mesenchyme: a new perspective for the treatment of biliary atresia? Eur J Pediatr Surg. 2001;11(6):382–390.
   PubMed Web of Science ®Google Scholar